Mengjia Song

发表

Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression

Yaojun Zhang, Jing-jing Zhao, Qi-jing Wang, 2021, Hepatology.

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2021, Cell Death & Disease.

The efﬁcacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

Yan Ding, Jing-jing Zhao, Qi-jing Wang, 2021 .

SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2022, International journal of biological sciences.

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma

Jing-jing Zhao, Qi-jing Wang, Qiu-zhong Pan, 2022, Cell Death & Disease.

Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

Min Li, J. Xia, Chao Yang, 2020, Journal of Hematology & Oncology.

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2020, British Journal of Cancer.

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2019, Aging.

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

F. Zhou, J. Xia, P. Dong, 2021, Clinical & translational immunology.

Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer

J. Xia, Yan Tang, D. Weng, 2020, Clinical & translational immunology.

Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker

J. Xia, Jiezhi Yang, D. Weng, 2021, Oncology letters.

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

J. Xia, Yan Tang, D. Weng, 2020, Oncoimmunology.

Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2023, Frontiers in immunology.

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

Z. Zhen, Suying Lu, F. Sun, 2024, Cell death & disease.

PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma

Suying Lu, F. Sun, Yan Tang, 2023, Oncoimmunology.